Viracor's Laboratory Advisory Board (LAB) is composed of distinguished scientific leaders whose deep expertise in laboratory science and diagnostics drives innovation and excellence. Their guidance ensures that Viracor remains at the forefront of cutting-edge testing and research, enabling us to meet evolving clinical needs, enhance diagnostic accuracy, and ultimately improve patient outcomes.

Dr. Micah Bhatti, MD, PhD

Associate Professor, Department of Laboratory Medicine
Division of Pathology/ Laboratory Medicine
The University of Texas

Dr. Micah Bhatti, MD, PhD, joins the Eurofins Viracor Laboratory Advisory Board as a distinguished Assistant Professor within the Department of Laboratory Medicine at The University of Texas. He received his medical degree from Indiana University School of Medicine. His expertise spans a wide range of laboratory medicine, with a particular focus on the intersection of pathology and clinical diagnostics.

His dual MD and PhD training provides a strong foundation in both clinical practice and translational research. This background allows him to bridge the gap between cutting-edge scientific discoveries and their practical applications in the diagnostic laboratory. Dr. Bhatti's research interests, as evidenced by his publications and presentations, often involve the development and implementation of advanced diagnostic techniques to improve patient outcomes. His experience in high-volume, complex patient settings brings practical knowledge to the advisory board.

Dr. Bhatti's commitment to advancing laboratory medicine and his dedication to improving patient care make him a valuable addition to the Eurofins Viracor Laboratory Advisory Board. His contributions will play a key role in guiding the laboratory's strategy and driving the advancement of cutting-edge diagnostic technologies.

Dr. Bronwen Garner, MD

System Director of Microbiology
Infectious Disease Specialist, Transplant
Piedmont Hospital Atlanta

Dr. Bronwen Garner, MD, joins the Eurofins Viracor Lab Advisory Board as the System Director of Microbiology for Piedmont Healthcare. Her unique background, encompassing international affairs, public health, and medicine, provides a broad perspective on the complexities of healthcare delivery. Dr. Garner's diverse educational foundation includes a Bachelor’s degree in International Affairs from Georgia Tech, a Master’s in Public Health with a concentration in Epidemiology from the University of Michigan, and a Doctorate of Medicine from the Medical College of Georgia, highlighting her commitment to both global and individual patient well-being.

As a US-trained infectious disease physician and medical microbiologist, Dr. Garner brings a wealth of clinical and laboratory expertise to the advisory board. Her top areas of expertise are transplant related infections including Cytomegalovirus Infection, Nocardiosis, and Pneumocystis Jiroveci Pneumonia. During her tenure as chair of the Infectious Disease Governance Council for Piedmont Healthcare, Garner was named Atlanta Business Chronicle’s 2021 Health Care Hero Rising Star. The Infectious Disease Governance Council provided Piedmont Healthcare (the largest healthcare system in Georgia) with evidence-based guidance on all infectious diseases. Her experience in leading and strategically growing clinical and laboratory programs positions her as a valuable asset in guiding Eurofins Viracor's initiatives. Her focus on strategic growth reflects a dedication to enhancing diagnostic capabilities and improving patient outcomes through effective leadership and innovative solutions.

Dr. Garner's passion for advancing microbiology and her commitment to strategic leadership make her an ideal addition to the Eurofins Viracor Lab Advisory Board. Her insights will significantly contribute to shaping the future of diagnostic services and supporting the provision of high-quality, patient-centered care.

Dr. Zoe Weiss, MD

Transplant ID Physician
Director, Clinical Microbiology Laboratory
Assistant Professor of Medicine
Pathology and Laboratory Medicine
Tufts University School of Medicine

Dr. Zoe Freeman Weiss is an attending physician in the Division of Infectious Diseases and Geographic Medicine at Tufts Medical Center and an Assistant Professor of Medicine at Tufts University School of Medicine. She is also an Assistant Professor and attending physician in the department of Anatomic and Clinical Pathology and serves as the Director of the Clinical Microbiology Laboratory. Dr. Weiss is also a valued member of the Eurofins Viracor Laboratory Advisory Board, bringing her extensive expertise in clinical microbiology and infectious diseases to guide the strategic direction of the laboratory.

Dr. Weiss received her medical degree from Warren Alpert Medical School of Brown University, followed by an internal medicine residency at the same institution. She completed her infectious disease fellowship, with a focus on transplant infectious diseases, and a medical microbiology fellowship (ABPath certified) at Brigham and Women's Hospital, Boston, MA. Her clinical interests focus on the care of transplant and other immunocompromised patients. She attends primarily on the transplant infectious diseases consultation services. She also provides clinical consultation within the microbiology laboratory and assists in the implementation and validation of new diagnostic tests. Her scholarly interests include the diagnosis of fungal infections in immunocompromised patients and the clinical applications of novel rapid diagnostic testing, such as Next-Generation-Sequencing and mass spectrometry.

Dr. Weiss was inducted into the Alpha Omega Alpha Honor Medical Society (ΑΩΑ), serves as a medical advisor to Anvil Diagnostics, and is a reviewer for the CLSI’s Antifungal subcommittee. In her current role, she is involved in laboratory administration/medical oversight, clinical research, and medical education. Her deep understanding of diagnostic testing and patient care will greatly benefit the Eurofins Viracor Laboratory Advisory Board's efforts to advance innovative diagnostic solutions.

Dr. Shaun Yang PhD, D(ABMM), MLS(ASCP)

Associate Clinical Professor, Pathology and Laboratory Medicine
Associate Medical Director, Clinical Microbiology Laboratory
Director, Molecular Microbiology and Pathogen Genomics (MMPG) Laboratory
UCLA School of Medicine

Dr. Shaun Yang joins the Eurofins Viracor Laboratory Advisory Board as a distinguished molecular biologist and clinical microbiologist. He brings extensive experience in clinical microbiology, clinical virology, molecular diagnostics, microbial genomics, genomic epidemiology, antimicrobial resistance, and transplant infectious disease diagnostics. He’s also a pioneer and thought leader in the clinical applications of next-generation sequencing (NGS) in infectious diseases.

Dr. Yang has developed and implemented numerous cutting-edge molecular microbiological tests and has authored or co-authored over 90 peer-reviewed papers and three book chapters. He is currently an Associate Clinical Professor in the Department of Pathology and Laboratory Medicine at the UCLA School of Medicine and serves as the Associate Medical Director of the Clinical Microbiology Laboratory. Additionally, Dr. Yang is the Director of the Molecular Microbiology and Pathogen Genomics (MMPG) Laboratory, which integrates advanced NGS technologies with pathogen-focused bioinformatics for microbial whole-genome sequencing (WGS) and metagenomics testing. His work addresses unmet clinical needs in diagnosing and treating complex infectious disease cases.

The MMPG Laboratory also conducts real-time, institution-level microbial genomic surveillance for outbreak investigations, emerging pathogen characterization, and antimicrobial resistance (AMR) monitoring, providing timely, actionable information to guide infection prevention and treatment optimization.

Dr. Yang earned a B.S. in Biotechnology from Peking University and a Ph.D. in Molecular Biology and Biochemistry from the University of Southern California. He completed Clinical and Public Health Microbiology Fellowship training at UCLA and became board-certified by the American Board of Medical Microbiology (ABMM) in 2016.

His primary research interests include molecular diagnostics test development and innovation, clinical applications of NGS, transplant-related infectious disease testing, genomic epidemiology, hospital outbreak investigation, and AMR mechanisms and genotypic prediction. Dr. Yang also collaborates internationally on the investigation and monitoring of emerging infectious diseases and novel AMR mechanisms.

An advocate and public speaker, Dr. Yang promotes vaccines, infection prevention, drug resistance awareness, and preparedness for emerging outbreaks. He is also an enthusiastic educator, dedicated to advancing public understanding of microbiology and infectious diseases, particularly among younger generations. His expertise will be instrumental in shaping the strategic direction of the Eurofins Viracor Laboratory Advisory Board and ensuring the delivery of high-quality, innovative diagnostic solutions.

Chat With An Expert

Back to top